<SEC-DOCUMENT>0001104659-18-017331.txt : 20180314
<SEC-HEADER>0001104659-18-017331.hdr.sgml : 20180314
<ACCEPTANCE-DATETIME>20180314094157
ACCESSION NUMBER:		0001104659-18-017331
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20180312
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180314
DATE AS OF CHANGE:		20180314

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BRUKER CORP
		CENTRAL INDEX KEY:			0001109354
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				043110160
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30833
		FILM NUMBER:		18688476

	BUSINESS ADDRESS:	
		STREET 1:		40 MANNING RD
		CITY:			BILLERICA
		STATE:			MA
		ZIP:			01821
		BUSINESS PHONE:		978663-3660

	MAIL ADDRESS:	
		STREET 1:		40 MANNING RD
		CITY:			BILLERICA
		STATE:			MA
		ZIP:			01821

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRUKER BIOSCIENCES CORP
		DATE OF NAME CHANGE:	20030721

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BRUKER DALTONICS INC
		DATE OF NAME CHANGE:	20000315
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a18-8257_18k.htm
<DESCRIPTION>8-K
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<div style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 3.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED STATES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, DC 20549</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade align="center" style="color:black;"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM&nbsp;8-K</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">CURRENT REPORT</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">Pursuant to Section&nbsp;13 OR 15(d)</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="3" face="Times New Roman" style="font-size:12.0pt;font-weight:bold;">of the Securities Exchange Act of 1934</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade align="center" style="color:black;"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date of Report (Date of earliest event reported): <b>March&nbsp;12, 2018</b></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">BRUKER CORPORATION </font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of registrant as specified in its charter)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware<br>    </font></b>(State or other jurisdiction<br>   of incorporation)</p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">000-30833<br>    </font></b>(Commission<br>   File Number)</p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="32%" valign="top" style="padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">04-3110160</font></b><br>   (IRS Employer<br>   Identification No.)</p>    </td>   </tr>  </table>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">40 Manning Road</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Billerica, MA 01821</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of principal executive offices)(Zip Code)</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Registrant&#146;s telephone number, including area code: <b>(978)&nbsp;663-3660</b></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade align="center" style="color:black;"></div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Check the appropriate box if the Form&nbsp;8-K filing is intended to simultaneously satisfy the reporting obligation of the registrant under any of the following provisions:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160; Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160; Soliciting material pursuant to Rule&nbsp;14a-12 of the Exchange Act (17 CFR 240.14a-12)</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160; Pre-commencement communications pursuant to Rule&nbsp;14d-2(b)&nbsp;under the Exchange Act (17 CFR 240.14d-2(b))</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Wingdings" style="font-size:10.0pt;">o</font>&#160;&#160;&#160;&#160; Pre-commencement communications pursuant to Rule&nbsp;13e-4(c)&nbsp;under the Exchange Act (17 CFR 240.13e-4(c))</p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&nbsp;405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule&nbsp;12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Emerging growth company&#160; </font><font face="Wingdings">o</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a)&nbsp;of the Exchange Act. </font><font face="Wingdings">o</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="border-bottom:solid windowtext 3.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109950\18-8257-1\task8786548\8257-1-ba.htm',USER='109950',CD='Mar 14 18:52 2018' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 5.02</font></b>&#160;&#160;&#160; <b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On March&nbsp;12, 2018, the Board of Directors of Bruker Corporation (&#147;Bruker,&#148; the &#147;Company,&#148; &#147;we&#148; or &#147;us&#148;) appointed Gerald N. Herman to serve as the Company&#146;s Interim Chief Financial Officer, effective as of March&nbsp;17, 2018 upon the departure of Chief Financial Officer and Senior Vice President Anthony L. Mattacchione. Mr.&nbsp;Mattacchione&#146;s resignation was previously reported in the Company&#146;s Form&nbsp;8-K filed with the Securities and Exchange Commission on February&nbsp;21, 2018. Mr.&nbsp;Herman, age 60, joined the Company in 2016 as Vice President and Corporate Controller and currently serves as principal accounting officer. Upon commencement of his service as Interim Chief Financial Officer, Mr.&nbsp;Herman also will serve as the Company&#146;s principal financial officer.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Prior to joining the Company, Mr.&nbsp;Herman was Corporate Vice President - Clinical Operations of PAREXEL International from 2014 to February&nbsp;2016 and Corporate Vice President&nbsp;&amp; Controller-Finance of PAREXEL from 2008 to 2013. From 2005 to 2008, Mr.&nbsp;Herman was Vice President-Corporate Controller of Presstek,&nbsp;Inc. Prior to 2005, he served in a variety of financial and accounting roles at various organizations, including as Senior Manager at Arthur Andersen LLP from 1979 to 1987. Mr.&nbsp;Herman is a Certified Public Accountant in the Commonwealth of Massachusetts and holds a M.B.A. from the University of Chicago and a Master of Science in Taxation from Bentley University.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">There is no arrangement or understanding between Mr.&nbsp;Herman and any other person pursuant to which Mr.&nbsp;Herman was appointed as Interim Chief Financial Officer of the Company. There are no transactions in which Mr.&nbsp;Herman has an interest requiring disclosure under Item 404(a)&nbsp;of Regulation S-K.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In connection with his appointment as Interim Chief Financial Officer, Mr.&nbsp;Herman&#146;s base salary of $250,000 will be increased by $6,000 per month from the effective date of his appointment. Additionally, he will be eligible to receive a special bonus, payable in April&nbsp;2019, in the amount of either $100,000 if selected as the Company&#146;s permanent Chief Financial Officer or $150,000 if an external candidate is appointed to that position, subject to continuation of employment and achievement of certain goals.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A copy of the Company&#146;s press release announcing Mr.&nbsp;Herman&#146;s appointment is attached as Exhibit&nbsp;99.1 to this Current Report on Form&nbsp;8-K.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 9.01&#160; Financial Statements and Exhibits.</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 5.4pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(d)</font></b>&#160;&#160;&#160;&#160;&#160; <b>Exhibits</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="94%" style="border-collapse:collapse;margin-left:.45in;">
<tr>
<td width="7%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:7.92%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Number</font></b></p>    </td>
<td width="4%" valign="bottom" style="padding:0in 0in 0in 0in;width:4.48%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="87%" valign="bottom" style="padding:0in 0in 0in 0in;width:87.6%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.48%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.6%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="7%" valign="top" style="padding:0in 0in 0in 0in;width:7.92%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99.1</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.48%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.6%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="a18-8257_1ex99d1.htm#Exhibit99_1_085434" title="Click to goto ">Press release dated March&nbsp;14, 2018.</a></font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="PB_2_084407_927"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\109950\18-8257-1\task8786548\8257-1-ba.htm',USER='109950',CD='Mar 14 18:52 2018' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURES</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:20.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BRUKER CORPORATION<br>   (Registrant)</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:49.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;Date: March&nbsp;14, 2018</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="44%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:44.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/FRANK H. LAUKIEN </font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="44%" valign="top" style="padding:0in 0in 0in 0in;width:44.84%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Frank H. Laukien</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="4%" valign="top" style="padding:0in 0in 0in 0in;width:4.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="44%" valign="top" style="padding:0in 0in 0in 0in;width:44.84%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Chairman,   President&nbsp;&amp; Chief Executive Officer</font></i></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="PB_3_084623_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\JMS\109950\18-8257-1\task8786548\8257-1-ba.htm',USER='109950',CD='Mar 14 18:52 2018' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a18-8257_1ex99d1.htm
<DESCRIPTION>EX-99.1
<TEXT>


<html>
<head>



  </head>
<body link=blue lang="EN-US">
<div>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;99.1<a name="Exhibit99_1_085434"></a></font></b></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-weight:bold;"><img width="147" height="83" src="g82571mmi001.gif"></font></b></p>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Bruker Appoints Gerald Herman as Interim Chief Financial Officer</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:49.6pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BILLERICA, Massachusetts &#151; March&nbsp;14, 2018 &#151; Bruker today announced that it has appointed Gerald N. Herman to serve as the Company&#146;s Interim Chief Financial Officer (CFO), effective as of March&nbsp;17, 2018.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:49.6pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr.&nbsp;Herman was recently also appointed as Bruker&#146;s Principal Accounting Officer (PAO), and he will assume his additional responsibilities as Interim CFO upon the departure of current CFO Anthony L. Mattacchione, whose resignation was announced in February&nbsp;2018.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:49.7pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Frank H. Laukien, President and CEO of Bruker Corporation, stated: &#147;I am very pleased to have Gerald as our Interim Chief Financial Officer and on my Executive Leadership Team.&#160; His diverse and deep background in finance and operations, including extensive international and manufacturing experience, will enable Gerald to be a strong Interim CFO for Bruker.&#160; Gerald&#146;s process, systems and operational focus are a great fit for the continued execution of Bruker&#146;s dual strategy of portfolio transformation and operational excellence.&#160; I look forward to working with Gerald on our key operational priorities and profitable growth initiatives, and to continuing to deliver on our financial commitments.&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="67%" valign="top" style="padding:0in 0in 0in 0in;width:67.84%;">
<p style="margin:0in 0in .0001pt;text-indent:49.7pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr.&nbsp;Herman   joined the Company in 2016 as Vice President and Corporate Controller. Prior   to joining Bruker, Mr.&nbsp;Herman had served in senior executive positions   with various publicly traded companies, including as Corporate Vice President   - Clinical Operations of PAREXEL International from 2014 to   February&nbsp;2016, and as Corporate Vice President&nbsp;&amp;   Controller-Finance of PAREXEL from 2008 to 2013. Prior to 2008,   Mr.&nbsp;Herman was Vice President - Corporate Controller of   Presstek,&nbsp;Inc. He also served in financial, consulting and accounting   roles at various organizations, including as Senior Manager at Arthur   Andersen LLP from 1979 to 1987. Mr.&nbsp;Herman is a Certified Public   Accountant (CPA) and holds a Master of Business Administration (MBA) from the   University of Chicago, and a Master of Science in Taxation from Bentley   University.</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;text-indent:49.7pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="30%" valign="top" style="padding:0in 0in 0in 0in;width:30.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman"><img width="124" height="173" src="g82571mmi002.jpg"></font></p>
<p style="margin:0in 0in .0001pt;"><font size="1" face="Times New Roman" style="font-size:5.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Mr.&nbsp;Gerald   Herman,&nbsp;Interim Chief Financial Officer of Bruker Corporation</font></i></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:49.6pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr.&nbsp;Herman commented: &#147;Bruker is a leader in the life science tools markets and carries an outstanding legacy of innovation and customer success.&#160; I am excited about the opportunity to work more closely with Frank and our strong leadership team to continue to support discoveries for our customers and drive value for our shareholders.&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:49.6pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Mr.&nbsp;John Ornell, the Chair of the Audit Committee of Bruker&#146;s Board of Directors, added: &#147;Gerald is an integral member of Bruker&#146;s senior finance leadership team and he has been heavily involved with the Company&#146;s margin enhancement initiatives, which will continue to be his focus as Interim CFO.&#160; I look forward to working closely with Gerald.&#148;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109760\18-8257-1\task8785994\8257-1-mm.htm',USER='109760',CD='Mar 14 09:01 2018' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">About Bruker Corporation (NASDAQ: BRKR)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker&#146;s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, phenomics and proteomics research, microbiology and molecular pathology research. For more information, please visit: www.bruker.com.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><u><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Investor Contact</font></u>:</b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Miroslava Minkova</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Head of Investor Relations</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Bruker Corporation</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">T: +1 (978) 663 &#151; 3660, ext. 1479</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">E: miroslava.minkova@bruker.com</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109760\18-8257-1\task8785994\8257-1-mm.htm',USER='109760',CD='Mar 14 09:01 2018' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g82571mmi001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g82571mmi001.gif
M1TE&.#=ADP!3 '<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M'$&"+SB#"U%R-'B#.)B#.KB#/-B#/OB#0!B$0CB$1%B$1GB$2)B$2O@2 0$
!.P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g82571mmi002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g82571mmi002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "M 'P# 2(  A$! Q$!_\0
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M2CTN:^?S9&(4]%]JMR#S;A(<\#EA6Y:0#8,5C4E9V1UX>DI+F9F6_A^!8\N
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BCO2'@9IB$9OEP*% VY-,IW;Z5-]1CLB@M@TWMFFT[@?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
